ASHLEIGH GENTLES: Open Payments
NPI 1427437185 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 31 payments from 10 companies in 2025. Trend: 2023 $204 · 2024 $740 · 2025 $1,570
Food & beverage: $862Travel & lodging: $708
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 18 | $1,290 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| CVRx, Inc. | 1 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ENDOTRONIX, INC. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Ancora Heart, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: CARDIOMEMS, LifeVest, Barostim Neo System, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR, ENTRESTO, VERQUVO, Wegovy, AccuCinch.
Industry payments across KS — which companies pay providers there.
